Henry Lynch, Leader in Cancer Genetics, Dies

The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.

Written byChia-Yi Hou
| 2 min read
Henry Lynch obituary cancer genetics hereditary syndrome breast ovarian

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A pioneer of cancer genetics, Henry Lynch, died on Sunday (June 2) at the age of 91, according to a press release from Creighton University, where he spent the bulk of his career. Lynch studied the cancer histories of more than 3,000 families to find genetic links to their diseases, states the release, ultimately discovering hereditary breast-ovarian cancer syndrome and hereditary nonpolyposis colon cancer.

“Henry Lynch occupies a distinguished place in the pantheon of the greatest cancer geneticists of the modern era,” says Kenneth Offit of Memorial Sloan Kettering Cancer Center to The Washington Post.

Lynch grew up in Depression-era New York. He is a veteran who served during World War II in the Pacific, according to the release. After his service, he was a professional boxer going by the nickname “Hammerin’ Hank,” until he returned to school in the late 1940s.

After completing doctoral work in human genetics from ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies